Filters applied below affect all components of the dashboard including the map, the data table, and any visualizations.

Data Type

Location

Seroprevalence and Viral Estimates

Human Estimates

Animal Estimates

MERSTracker (by the SeroTracker group) is a dashboard displaying published MERS-CoV serosurveys, viral testing, and genomic sequencing studies. We compile and centralize resources on MERS-CoV via a systematic review of available literature. Our database is not comprehensive and we continue to add studies with new searches. You can see more information on our review methods

here

.

The data on our dashboard are extracted from publicly available independent research and do not reflect validation of the findings on behalf of SeroTracker or any of our funding or collaborating partners. Research studies are heterogeneous and vary in their quality, design, methodology, assay performance, and reporting, and results should be interpreted and compared with caution.

The last major update to our data was on November 9th 2024

Loading...

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of WHO, FAO, SeroTracker, or SeroTracker's partners concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

Note: Dotted lines represent approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties. The final boundary between the Republic of South Sudan and the Republic of the Sudan has not yet been determined.

No data available for table.

For

Tested Using

Assays And Grouped By

With 95% Confidence Intervals

No data.

SeroTracker Research Group (2024); MERSTracker Dashboard. Website, accessible via https://new.serotracker.com/

Screening assays detect antibodies to MERS-CoV typically using recombinant spike and nucleocapsid proteins. Confirmatory assays detect neutralizing antibodies to MERS-CoV using live virus or pseudotyped particles and are recommended to confirm positive screening results.

By

For

Over Time

No data.

SeroTracker Research Group (2024); MERSTracker Dashboard. Website, accessible via https://new.serotracker.com/

      Welcome to MERSTracker!

      MERSTracker (by the SeroTracker group) is a dashboard displaying published MERS-CoV serosurveys, viral testing, and genomic sequencing studies. We compile and centralize resources on MERS-CoV via a systematic review of available literature. Our database is not comprehensive and we continue to add studies with new searches. You can see more information on our review methods

      here

      .

      The data on our dashboard are extracted from publicly available independent research and do not reflect validation of the findings on behalf of SeroTracker or any of our funding or collaborating partners. Research studies are heterogeneous and vary in their quality, design, methodology, assay performance, and reporting, and results should be interpreted and compared with caution.